Benefits

What higher testosterone has been shown to do.

Every category below is drawn from published clinical literature — controlled trials, long-term registries and population studies. Together they describe one thing: testosterone optimisation is an anti-ageing and longevity intervention that happens to be measurable.

Type 2 diabetes

  • Tissue glucose uptake in response to insulin rises by 32–35%.
  • ~34% of hypogonadal diabetic men reached full remission over 11 years of therapy.
  • New-onset diabetes markedly reduced versus lifestyle intervention alone.
  • HbA1c falls 1.0–1.5 percentage points and stays down as visceral fat is lost.

References

  • Dhindsa & Dandona, Diabetes Care 2016
  • Haider et al., DOM 2020
  • Wittert et al., T4DM, Lancet D&E 2021

Metabolic syndrome & pre-diabetes

  • Waist circumference, triglycerides and blood pressure improve together as visceral fat falls.
  • Breaks the aromatase loop in which belly fat converts testosterone into estrogen.
  • Fasting insulin and hs-CRP decline, reducing low-grade systemic inflammation.

References

  • Traish, World J Men's Health 2014
  • Saad et al., registry data

Cardiovascular health

  • Long-term registry follow-up shows improved lipid profile and blood pressure.
  • Normalising testosterone in deficient men is associated with lower cardiovascular mortality than remaining untreated.
  • Endothelial function and exercise capacity improve in men with heart failure and low testosterone.

References

  • Traish 2014
  • Sharma et al., Eur Heart J 2015
  • Malkin et al., Eur Heart J 2006

Muscle mass & strength

  • Lean mass rises 5–7 kg with dose-dependent gains in leg press and bench strength.
  • Dose–response is linear across the physiological range — the level, not merely 'being on therapy', decides the result.
  • Reverses age-related sarcopenia and restores resting metabolic rate.

References

  • Bhasin et al., NEJM 1996
  • Bhasin et al., AJP-Endo 2001

Bone density & osteoporosis

  • Lumbar spine bone mineral density increases roughly 8% over long-term therapy.
  • Bone remodelling accelerates at upper-physiological levels; osteoporosis progression is arrested.
  • Fracture risk falls as density and muscular protection are restored.

References

  • Snyder et al., JCEM (BMD substudy)
  • Traish 2014

Mood, motivation & well-being

  • Depressive symptom scores improve in men with low testosterone.
  • Drive, concentration and emotional resilience return — the domain most often misdiagnosed as burnout.
  • Fatigue is the earliest and most consistently reversed symptom.

References

  • Wu et al., EMAS, NEJM 2010
  • Zarrouf et al., J Psychiatr Pract 2009

Libido, erections & drive

  • Sexual desire, morning erections and erectile firmness improve in a dose-dependent way.
  • Symptom burden tracks free testosterone, not total testosterone — which is why bioavailable hormone must be measured.

References

  • Wu et al., EMAS, NEJM 2010
  • Snyder et al., NEJM 2016 (Sexual Function Trial)

Anti-ageing, skin & longevity

  • Topical testosterone thickened atrophic aged skin and restored dermal structure.
  • Every major hallmark of ageing — sarcopenia, bone loss, insulin resistance, inflammation, flattened drive — overlaps with androgen deficiency.
  • Optimisation is a longevity intervention, not a cosmetic one: it addresses the physiology that determines healthspan.

References

  • Papa, J Invest Dermatol 1967
  • Traish 2014

Find out where you actually sit.

None of this applies until you measure. Take the international symptom questionnaire, then confirm with an LC-MS/MS finger-prick test.